Patents Assigned to HEARTFORD HEALTH SYSTEM
  • Patent number: 9375313
    Abstract: Cardiomyopathy may be treated by distributing space-occupying agent within the myocardium in a pattern about one or more chambers of the heart, such that the space-modifying agent integrates into and thickens at least part of the cardiac wall about the chamber so as globally to reduce wall stress and stabilize or even reduce chamber size. Some patterns also cause a beneficial global reshaping of the chamber. These changes occur quickly and are sustainable, and have a rapid and sustainable therapeutic effect on cardiac function. Over time the relief of wall stress reduces oxygen consumption and promotes healing. Moreover, various long-term therapeutic effects may be realized depending on the properties of the space-occupying agent, including combinations with other therapeutic materials. These techniques may also be used to treat localized conditions, whether or not they have progressed to cardiomyopathy.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: June 28, 2016
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, HEARTFORD HEALTH SYSTEM, CARDIOPOLYMERS, INC.
    Inventors: Hani N. Sabbah, Randall J. Lee, Andrew G. Hinson